
Intuitive Surgical (ISRG) Stock Forecast & Price Target
Intuitive Surgical (ISRG) Analyst Ratings
Bulls say
Intuitive Surgical is well-positioned to benefit from the growing roboticsurgery market, with over 10,000 da Vinci systems placed worldwide and a low globalpenetration of less than 5%. With the recent launch of the DV5 robotic system and plans for further enhancements, Intuitive is poised for continued growth and potentially re-accelerated procedure growth. The company's strong financials and history of investing in innovation, such as their recently-announced extended-use instrument program and plans for a new GI/endoscopy robot, demonstrate their commitment to driving future growth. While there are concerns about competition and market uncertainties, Intuitive's dominant market position and strong balance sheet provide a sustainable advantage for years to come.
Bears say
Intuitive Surgical is facing significant challenges, reflected in their consecutive downward revisions for higher price targets as they posted a solid 2Q with procedure growth (~16%), which implies a slight slowdown. While their recent survey shows dominant competitiveness, the company continues to face headwinds like the ACA subsidy expiration and more challenging procedures. Moreover, ASPs are decreasing with every quarter, which suggests a possible downward trend in demand over the long term.
This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.
Intuitive Surgical (ISRG) Analyst Forecast & Price Prediction
Start investing in Intuitive Surgical (ISRG)
Order type
Buy in
Order amount
Est. shares
0 shares